- Trials with a EudraCT protocol (3,184)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
3,184 result(s) found for: 4 mg single dose.
Displaying page 51 of 160.
EudraCT Number: 2016-001832-36 | Sponsor Protocol Number: 204959 | Start Date*: 2017-05-15 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: An open-label, single arm, repeat dose, multi-centre study to evaluate the use of an autoinjector for the subcutaneous administration of mepolizumab in subjects with severe eosinophilic asthma (Stu... | |||||||||||||
Medical condition: Severe eosinophilic asthma | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) SE (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000181-37 | Sponsor Protocol Number: CVT-301-002 | Start Date*: 2012-04-25 | |||||||||||
Sponsor Name:Civitas Therapeutics, Inc. | |||||||||||||
Full Title: A Randomized, Placebo-Controlled Phase 2 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CVT-301 (Levodopa Inhalation Powder) in Patients with Parkinson’s Disease and Motor Response ... | |||||||||||||
Medical condition: Parkinson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016525-34 | Sponsor Protocol Number: 28431754DIA3006 | Start Date*: 2010-04-21 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-28431754 (Canagliflozin) Compared with... | |||||||||||||
Medical condition: Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) BG (Completed) PT (Prematurely Ended) PL (Completed) SK (Completed) CZ (Completed) EE (Completed) SE (Completed) GR (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005594-21 | Sponsor Protocol Number: ADP-04511 | Start Date*: 2016-08-18 | |||||||||||
Sponsor Name:Adaptimmune LLC | |||||||||||||
Full Title: A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1c259T in HLA-A2+ Patients with Synovial Sarcoma | |||||||||||||
Medical condition: Unresectable, metastatic or recurrent synovial sarcomas | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002067-20 | Sponsor Protocol Number: RA0077 | Start Date*: 2012-06-13 | |||||||||||
Sponsor Name:UCB Pharma SA | |||||||||||||
Full Title: A multicenter, single blind, randomized parallel group study to assess the short and long term efficacy of certolizumab pegol plus methotrexate compared with adalimumab plus methotrexate in subject... | |||||||||||||
Medical condition: Moderate to severe rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) HU (Completed) PT (Completed) AT (Completed) IE (Completed) CZ (Completed) ES (Completed) BG (Completed) FR (Completed) IT (Completed) GR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000955-28 | Sponsor Protocol Number: R668-AD-1539 | Start Date*: 2018-05-23 | |||||||||||
Sponsor Name:Regeneron Pharmaceuticals, Inc. | |||||||||||||
Full Title: A phase 2/3 study investigating the pharmacokinetics, safety, and efficacy of Dupilumab in patients aged ≥6 months to <6 years with moderate-to-severe atopic dermatitis | |||||||||||||
Medical condition: Part B: Moderate to Severe Atopic Dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004276-49 | Sponsor Protocol Number: CD-LAQ-201 | Start Date*: 2008-09-16 | |||||||||||
Sponsor Name:Teva Pharmaceutical Industries Ltd. | |||||||||||||
Full Title: Estudio de fase IIa, multicéntrico, randomizado, doble ciego, controlado con placebo, de cohortes secuenciales, de búsqueda de rango de dosis para evaluar la seguridad, tolerabilidad y el efecto cl... | |||||||||||||
Medical condition: Enfermedad de Crohn activa de moderada a grave | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) FR (Completed) IT (Completed) NL (Completed) BE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004481-16 | Sponsor Protocol Number: VRA105345 | Start Date*: 2005-12-19 |
Sponsor Name:GlaxoSmithKline Research and Development | ||
Full Title: A multi-centre, randomised, single blind, placebo controlled, parallel group study to examine the effect of single doses of SB-705498, a TRPV1 receptor antagonist, on pain following third molar too... | ||
Medical condition: Dental pain | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-005030-38 | Sponsor Protocol Number: PAT-CR-302 | Start Date*: 2019-08-10 | |||||||||||
Sponsor Name:Vifor Pharma, Inc. | |||||||||||||
Full Title: A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin-Aldosterone Syst... | |||||||||||||
Medical condition: Management of hyperkalemia due to renin-angiotension-aldosterone system medications in patients treated for heart failure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) CZ (Completed) NL (Completed) ES (Ongoing) HU (Completed) DE (Completed) BG (Completed) GB (GB - no longer in EU/EEA) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001361-12 | Sponsor Protocol Number: FG001-CT-003 | Start Date*: 2022-08-25 | ||||||||||||||||
Sponsor Name:FluoGuide A/S | ||||||||||||||||||
Full Title: An open-label, non-randomized, single center, single dose, exploratory phase II trial of FG001 (an imaging agent) for localization of oral and oropharyngeal squamous cell carcinoma | ||||||||||||||||||
Medical condition: Oral and oropharyngeal squamous cell carcinoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-000872-18 | Sponsor Protocol Number: WA18221 | Start Date*: 2008-04-15 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd. | |||||||||||||
Full Title: A 12-week randomized, double blind, placebo-controlled, parallel group, 2-arm study to evaluate the efficacy and safety of tocilizumab in patients with active systemic juvenile idiopathic arthritis... | |||||||||||||
Medical condition: Systemic Juvenile Idiopathic Arthritis (sJIA) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) SE (Completed) DE (Completed) NO (Ongoing) CZ (Completed) ES (Completed) DK (Completed) NL (Completed) GR (Completed) SK (Completed) IT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005068-29 | Sponsor Protocol Number: C2006-01 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:A.P. Pharma, Inc. | |||||||||||||
Full Title: A Pivotal Phase 3 Observer-Blind, Randomized Clinical Trial of the Efficacy and Safety of APF530 Compared to Aloxi® for the Prevention of Acute-Onset and Delayed-Onset Chemotherapy-Induced Nausea a... | |||||||||||||
Medical condition: Chemotherapy Induced Nausea and Vomiting | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003022-22 | Sponsor Protocol Number: SOLTI-1904 | Start Date*: 2021-02-26 |
Sponsor Name:SOLTI | ||
Full Title: EfficACy of Spartalizumab acROss multiPle cancer-types in patients with PD1-high mRNA expressing tumOrs defined by a singLe and pre-specIfied cutoff | ||
Medical condition: Metastatic disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004040-36 | Sponsor Protocol Number: CE01-302 | Start Date*: 2014-10-10 |
Sponsor Name:Cempra Pharmaceuticals, Inc. | ||
Full Title: A Study to Evaluate the Efficacy and Safety of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea (SOLITAIRE-U). | ||
Medical condition: gonorrhoea | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: (No results available) |
EudraCT Number: 2010-023414-31 | Sponsor Protocol Number: MD-KPSY-01/10 | Start Date*: 2012-03-05 |
Sponsor Name:Medizinische Fakultät. Otto von Guericke Universität | ||
Full Title: Ketamine in treatment resistant major depression (TRD) | ||
Medical condition: Therapy resistant depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001921-19 | Sponsor Protocol Number: BUSCAPART | Start Date*: 2014-02-11 | |||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||
Full Title: Randomised, masked, placebo-controlled study to evaluate the effects of a single intravenous dose of hyoscine bromide on the duration and pain in the latent and active labor | |||||||||||||
Medical condition: labor | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022084-36 | Sponsor Protocol Number: rhLAMAN-02 | Start Date*: 2010-10-05 |
Sponsor Name:Zymenex A/S | ||
Full Title: A single center, open-label, dose escalation study of the safety and pharmacokinetics of rhLAMAN (recombinant human alpha-mannosidase or Lamazym) for the treatment of patients with alpha-mannosidosis. | ||
Medical condition: Treatment of alpha-Mannosidosis | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001235-20 | Sponsor Protocol Number: 14.0189 | Start Date*: 2015-06-05 |
Sponsor Name:St George's University of London | ||
Full Title: Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease | ||
Medical condition: PARTICIPANTS WITH EVIDENCE OF CEREBRAL SMALL VESSEL DISEASE | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001425-48 | Sponsor Protocol Number: BLUEBERRY | Start Date*: 2021-07-07 |
Sponsor Name:Division of Anaesthesiology - Department of Acute Medicine - Geneva Children's Hospital, University Hospitals of Geneva | ||
Full Title: Dexamethasone and postoperative bleeding following tonsillectomy in children | ||
Medical condition: Tonsillectomy/tonsillotomy | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2009-015796-27 | Sponsor Protocol Number: SMA-09-18 | Start Date*: 2009-11-12 |
Sponsor Name:Alcon d.o.o. | ||
Full Title: Patient Preference Comparison of Azarga versus Cosopt, after Single Doses in Patients with Open-Angled Glaucoma or Ocular Hypertension | ||
Medical condition: Open-angle glaucoma or ocular hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SI (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
